290 related articles for article (PubMed ID: 33155285)
1. The importance of assessing blood tumour burden in cutaneous T-cell lymphoma.
Vermeer MH; Nicolay JP; Scarisbrick JJ; Zinzani PL
Br J Dermatol; 2021 Jul; 185(1):19-25. PubMed ID: 33155285
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry for the assessment of blood tumour burden in cutaneous T-cell lymphoma: towards a standardized approach.
Vermeer MH; Moins-Teisserenc H; Bagot M; Quaglino P; Whittaker S
Br J Dermatol; 2022 Jul; 187(1):21-28. PubMed ID: 35157307
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.
Hristov AC; Tejasvi T; Wilcox RA
Am J Hematol; 2023 Jan; 98(1):193-209. PubMed ID: 36226409
[TBL] [Abstract][Full Text] [Related]
5. Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force.
Scarisbrick JJ; Hodak E; Bagot M; Stranzenbach R; Stadler R; Ortiz-Romero PL; Papadavid E; Evison F; Knobler R; Quaglino P; Vermeer MH
Eur J Cancer; 2018 Apr; 93():47-56. PubMed ID: 29477101
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
7. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.
Benton EC; Crichton S; Talpur R; Agar NS; Fields PA; Wedgeworth E; Mitchell TJ; Cox M; Ferreira S; Liu P; Robson A; Calonje E; Stefanato CM; Wilkins B; Scarisbrick J; Wain EM; Child F; Morris S; Duvic M; Whittaker SJ
Eur J Cancer; 2013 Sep; 49(13):2859-68. PubMed ID: 23735705
[TBL] [Abstract][Full Text] [Related]
8. Mycosis fungoides and Sézary syndrome.
Jonak C; Tittes J; Brunner PM; Guenova E
J Dtsch Dermatol Ges; 2021 Sep; 19(9):1307-1334. PubMed ID: 34541796
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostics of primary cutaneous lymphomas].
Felcht M; Hillen U; Klemke CD
Hautarzt; 2017 Sep; 68(9):696-701. PubMed ID: 28779267
[TBL] [Abstract][Full Text] [Related]
10. Memorials and mandates for cutaneous lymphomas.
Heald PW
Arch Dermatol; 2003 Jul; 139(7):926-8. PubMed ID: 12873891
[No Abstract] [Full Text] [Related]
11. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
[TBL] [Abstract][Full Text] [Related]
12. Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.
Hughes CF; Newland K; McCormack C; Lade S; Prince HM
Australas J Dermatol; 2016 Aug; 57(3):182-91. PubMed ID: 25988337
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.
Hristov AC; Tejasvi T; A Wilcox R
Am J Hematol; 2021 Oct; 96(10):1313-1328. PubMed ID: 34297414
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous lymphomas: exploration of 10-year data from supraregional mutlidisciplinary team meetings in Glasgow, UK.
McCusker S; Ngu I
Clin Exp Dermatol; 2023 Aug; 48(9):1036-1039. PubMed ID: 37140442
[TBL] [Abstract][Full Text] [Related]
15. [Mycosis fungoides and Sézary syndrome : a systematic review].
André F; Guenova E; Blanchard G
Rev Med Suisse; 2022 Mar; 18(775):578-589. PubMed ID: 35353453
[TBL] [Abstract][Full Text] [Related]
16. Therapy of cutaneous lymphoma--current practice and future developments.
Dummer R; Kempf W; Hess Schmid M; Häffner A; Burg G
Onkologie; 2003 Aug; 26(4):366-72. PubMed ID: 12972705
[TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.
Oh Y; Stoll JR; Moskowitz A; Pulitzer M; Horwitz S; Myskowski P; Noor SJ
J Am Acad Dermatol; 2021 Nov; 85(5):1093-1106. PubMed ID: 33945836
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update.
Parker SR; Bethaney JV
G Ital Dermatol Venereol; 2009 Aug; 144(4):467-85. PubMed ID: 19755952
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous T-cell lymphoma-Focus on some problems, and some solutions.
Beltraminelli H
Hematol Oncol; 2023 Jun; 41 Suppl 1():20-24. PubMed ID: 37294972
[TBL] [Abstract][Full Text] [Related]
20. [Cutaneous T-cell lymphoma].
Dippel E; Gellrich S; Klemke CD; Goerdt S; Sterry W
J Dtsch Dermatol Ges; 2003 Dec; 1(12):965-80; quiz 981-2. PubMed ID: 16285650
[No Abstract] [Full Text] [Related]
[Next] [New Search]
